Feed aggregator

Most Popular NEJM Group Feature This Week: Time to Get Rid of Food Tongs?

Physician's First Watch - 8 hours 37 min ago
Here's our most clicked-on item from NEJM Group this week, in case you missed it the first time around: HIV and ID Observations: Dr...
Categories: News

Your NEJM Group Today: "Popeye" Sign Image / Skin Patches for Peanut Allergy? / San Francisco Primary Care Opportunities

Physician's First Watch - 8 hours 37 min ago
Here's what we chose for you from NEJM Group today: NEJM Clinical Practice Center: Image in Clinical Medicine: A 79-year-old man presented with...
Categories: News

Gynecology Group Names 5 Treatments, Procedures to Avoid

Physician's First Watch - 8 hours 37 min ago
The AAGL (formerly, the American Association of Gynecologic Laparoscopists) has named five treatments and procedures clinicians should question as part of the American Board of...
Categories: News

A Closer Look: Heart Groups Lower Threshold for Hypertension

Physician's First Watch - 8 hours 37 min ago
Earlier this week, the American College of Cardiology and the American Heart Association, among others, announced new cutoffs for hypertension as part of their updated...
Categories: News

Baby Boomers at Lower Risk for Macular Degeneration Than Their Predecessors

Physician's First Watch - 8 hours 37 min ago
Baby Boomers appear less likely than their predecessors to develop macular degeneration, according to a study in JAMA Ophthalmology. Researchers examined nearly 5000 adults in...
Categories: News

Your NEJM Group Today: Next Steps in Gene Editing / AHA 2017 News Roundup / Alaska FM Opportunity

Physician's First Watch - 8 hours 37 min ago
Here's what we chose for you from NEJM Group today: NEJM Audio Interview: Next Steps in Gene Editing: Dr. George Church discusses recent advances in...
Categories: News

FDA Looking at Potentially Increased Mortality Risk with Gout Drug

Physician's First Watch - 8 hours 37 min ago
The FDA is investigating whether the gout drug febuxostat (Uloric) is associated with an increased risk for heart-related mortality. This follows a postmarketing trial...
Categories: News

Dads' Depression Tied to Increased Depression Risk in Teenage Children

Physician's First Watch - 8 hours 37 min ago
Children with depressed fathers are at increased risk for developing depression themselves when they reach adolescence, according to a Lancet Psychiatry study. The study included...
Categories: News

FDA Clears Nerve Stimulator to Treat Opioid Withdrawal Symptoms

Physician's First Watch - 8 hours 37 min ago
A percutaneous nerve stimulator previously approved for use in acupuncture may now be used to help ease the physical symptoms of opioid withdrawal, the FDA...
Categories: News

Kids Having Tonsillectomy, Adenoidectomy Still Get Codeine Despite Decreasing Prescriptions

Physician's First Watch - 8 hours 37 min ago
Clinicians have eased off prescribing codeine to children undergoing tonsillectomy or adenoidectomy, but 1 in 20 patients still receives codeine, a Pediatrics study finds. In...
Categories: News

FDA permits marketing of first electric stimulation device to reduce opioid withdrawal symptoms

News-Medical.Net Pharmaceutical News - Thu, 2017-11-16 01:20
Today, the U.S. Food and Drug Administration granted a new indication to an electric stimulation device for use in helping to reduce the symptoms of opioid withdrawal.
Categories: News

New study identifies chemical receptors in cells to reduce drug resistance

News-Medical.Net Pharmaceutical News - Wed, 2017-11-15 20:58
The bacterium Pseudomonas aeruginosa is the leading cause of hospital-acquired infections. The pathogen is resistant to many antibiotics so treating those infections, particularly in patients with compromised immune systems, is difficult.
Categories: News

FDA approves drug to treat pediatric, adult patients with rare Sly syndrome

News-Medical.Net Pharmaceutical News - Wed, 2017-11-15 18:51
The U.S. Food and Drug Administration today approved Mepsevii (vestronidase alfa-vjbk) to treat pediatric and adult patients with an inherited metabolic condition called mucopolysaccharidosis type VII (MPS VII), also known as Sly syndrome. MPS VII is an extremely rare, progressive condition that affects most tissues and organs.
Categories: News

AstraZeneca’s new precision biologic gets FDA approval to treat severe eosinophilic asthma

News-Medical.Net Pharmaceutical News - Tue, 2017-11-14 19:59
AstraZeneca and its global biologics research and development arm, MedImmune, today announced that the US Food and Drug Administration has approved FASENRA (benralizumab) for the add-on maintenance treatment of patients with severe asthma aged 12 years and older, and with an eosinophilic phenotype.
Categories: News

Medicaid coverage for methadone could improve outcomes for pregnant women with OUD

News-Medical.Net Pharmaceutical News - Tue, 2017-11-14 19:25
Pregnant women with opioid use disorder (OUD) are more likely to receive evidence-based treatment with an "opioid agonist"- usually methadone- in states where those medications are covered by Medicaid, reports a study in the December issue of Medical Care, published by Wolters Kluwer.
Categories: News

FDA issues warning against use of herbal medicine Kratom

News-Medical.Net Pharmaceutical News - Tue, 2017-11-14 19:16
The United States Food and Drugs Administration (FDA) has issued a public notice yesterday, 14th November 2017, regarding the risks associated with herbal drug Kratom. Kratom has been used for a long time and still finds numerous users.
Categories: News

FDA approves first digital pill with sensor - Abilify MyCite

News-Medical.Net Pharmaceutical News - Tue, 2017-11-14 19:07
The United States Food and Drugs Administration (FDA), for the first time has approved a digital pill system. The novel pill comes with an in-built sensor that transmits information to a remote location after a person has taken it. Experts believe this is a huge step towards digital medicine and opens new avenues for therapy and diagnostics.
Categories: News

Manganese dioxide could make preparation of micromotors more cost-effective

News-Medical.Net Pharmaceutical News - Tue, 2017-11-14 07:53
Manganese dioxide could make the preparation of micromotors increasingly cost-effective, opening up new avenues for their use, according to a new study from the University of Eastern Finland.
Categories: News
Syndicate content